In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
410 News Items found
A sign welcomes attendees to the AACR meeting in New Orleans.
Roundup
MSK’s Research Roundup at AACR 2022: Targeted Therapy for Lung Cancer, Using Statins With a Breast Cancer Drug, and Diagnosing Blood Cancer

MSK studies presented at the 2022 American Association for Cancer Research meeting include updates on a targeted therapy for lung cancer, lab research on combining statins with a breast cancer drug, and a new tool for diagnosing blood cancer.
Jung Hun Oh
Pregnancy-Related Proteins in Tumors Linked to Worse Survival in Female Lung Cancer Patients

Lung cancer co-opts genes that normally help a fetus develop and evade the mother’s immune system — leading to poorer outcomes in female patients, an MSK research team has found.
MSK scientists Charles Rudin and John Poirier
In the Lab
Scientists Home in on Treatment Advance for Chemotherapy-Resistant Small Cell Lung Cancer

An epigenetic mechanism may make small cell lung cancer vulnerable to a new kind of attack.
A tube of blood superimposed on a lung and a DNA helix
In the Clinic
Liquid Biopsy Is Effective at Guiding Treatment of Lung Cancer, Study Finds

The initial results of an ongoing study show that a liquid biopsy has advantages over a tissue biopsy for people with lung cancer.
scientific image
In the Clinic
Personalized Medicine 2.0: MSK Leads the Way in the Study of Drug Resistance in Lung Cancer

Overcoming resistance to drug treatment for lung cancer is a critical challenge.
Charles Rudin and David Jones, leaders of the Druckenmiller Center
In the Clinic
MSK’s New Fiona and Stanley Druckenmiller Center for Lung Cancer Research Takes on Biggest Cancer Killer

The new Fiona and Stanley Druckenmiller Center for Lung Cancer Research brings together MSK physicians and scientists in an intensive, multidisciplinary effort against the number-one cause of death from cancer in the nation.
Memorial Sloan Kettering neuro-oncologist Adrienne Boire
Roundup
Year in Review: Five Important Clinical Advances in Cancer in 2020

Read about some of the most important clinical advances made at MSK in 2020.
Charles Rudin and Dana Pe'er
Molecular Atlas of Small Cell Lung Cancer Reveals Unusual Cell Type That Could Explain Why It’s So Aggressive

Stem-like cells that make up only a tiny fraction of the total cells in a lung tumor could be the key to stopping the disease’s deadly spread, say researchers at Memorial Sloan Kettering.
Three photos of Karen Milich: one with her grandson, one of her with her sons, and one of her alone
Feature
How Four Decades of Research Led to an Important Advance in Lung Cancer

Read how a clinical trial is changing the outlook for some people with lung cancer.
MSK Scientists Reveal Biology of Shape-Shifting Lung Cancer

Lung cancer has an uncanny ability to change its identity to resist drugs. Researchers are learning what drives these changes.